April 27, 2012
It is a pleasure for BCN Peptides to inform you, that between April 23rd-26th 2012, we have been audited by the US FDA for the third time in the last years. At the end of the four days audit, the inspectors recommended the FDA approval without any observation (no 483 was issued).
This new “FDA approval” is a confirmation that our company follows the highest Quality Standards in the manufacturing of Active Pharmaceuticals Ingredients. BCN Peptides keeps working hard to be able to offer to its customers the best services and quality products always in strict compliance with the international standards.